SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-187585
Filing Date
2022-07-05
Accepted
2022-07-05 08:48:35
Documents
14
Period of Report
2022-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d357275d8k.htm   iXBRL 8-K 27996
2 EX-99.1 d357275dex991.htm EX-99.1 9710
6 GRAPHIC g357275g17w54.jpg GRAPHIC 16163
  Complete submission text file 0001193125-22-187585.txt   183413

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20220628.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20220628_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20220628_pre.xml EX-101.PRE 10823
8 EXTRACTED XBRL INSTANCE DOCUMENT d357275d8k_htm.xml XML 3225
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 221063306
SIC: 2834 Pharmaceutical Preparations